Protective effects of a potent C5a receptor antagonist on experimental acute limb ischemia-reperfusion in rats

Journal of Surgical Research

Volumn 116, Issue 1, 2004, Pages 81-90

  Woodruff, Trent M ^a   Arumugam, Thiruma V ^a   Shiels, Ian A ^a   Reid, Robert C ^a   Fairlie, David P ^a   Taylor, Stephen M ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Acute limb ischemia; Antiinflammatory; C5a receptor antagonist; Ischemia reperfusion injury

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CALCIUM; COMPLEMENT COMPONENT C5A RECEPTOR BLOCKING AGENT; CREATINE KINASE; CREATININE; LACTATE DEHYDROGENASE; MYELOPEROXIDASE; NITROGEN; POTASSIUM; PROTEIN; RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UREA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CALCIUM CELL LEVEL; CELL PROTECTION; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; ENZYME BLOOD LEVEL; EXPERIMENTAL HOST; FEMALE; HINDLIMB; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER; LIVER HOMOGENATE; LUNG; MUSCLE; NONHUMAN; PERIPHERAL EDEMA; PERIPHERAL ISCHEMIA; POLYMORPHONUCLEAR CELL; POTASSIUM CELL LEVEL; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; REPERFUSION INJURY; UREA NITROGEN BLOOD LEVEL;

EID: 0345829310     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jss.2003.04.001     Document Type: Article

References (51)

1. Kerrigan C.L., Stotland M.A. Ischemia reperfusion injury A review . Microsurgery. 14:1993;165.
2. Carter W.O., Bull C., Bortolon E., Yang L., Jesmok G.J., Gundel R.H. A murine skeletal muscle ischemia-reperfusion injury model Differential pathology in BALB/c and DBA/2N mice . J. Appl. Physiol. 85:1998;1676.
3. Papanastasiou S., Estdale S.E., Homer-Vanniasinkam S., Mathie R.T. Protective effect of preconditioning and adenosine pretreatment in experimental skeletal muscle reperfusion injury. Br. J. Surg. 86:1999;916.
4. Defraigne J.O., Pincemail J. Local and systemic consequences of severe ischemia and reperfusion of the skeletal muscle. Physiopathology and prevention. Acta Chir. Belg. 97:1997;176.
5. Lindsay T.F., Hill J., Ortiz F., Rudolph A., Valeri C.R., Hechtman H.B., Moore F.D. Jr. Blockade of complement activation prevents local and pulmonary albumin leak after lower torso ischemia-reperfusion. Ann. Surg. 216:1992;677.
6. Wakai A., Winter D.C., Street J.T., O'Sullivan R.G., Wang J.H., Redmond H.P. Inosine attenuates tourniquet-induced skeletal muscle reperfusion injury. J. Surg. Res. 99:2001;311.
7. Kyriakides C., Favuzza J., Wang Y., Austen W.G. Jr, Moore F.D. Jr, Hechtman H.B. Recombinant soluble P-selectin glycoprotein ligand 1 moderates local and remote injuries following experimental lower-torso ischemia. Br. J. Surg. 88:2001;825.
8. Brock R.W., Carson M.W., Harris K.A., Potter R.F. Microcirculatory perfusion deficits are not essential for remote parenchymal injury within the liver. Am. J. Physiol. 277:1999;G55.
9. Vega V.L., Mardones L., Maldonado M., Nicovani S., Manriquez V., Roa J., Ward P.H. Xanthine oxidase released from reperfused hind limbs mediate kupffer cell activation, neutrophil sequestration, and hepatic oxidative stress in rats subjected to tourniquet shock. Shock. 14:2000;565.
10. Brock R.W., Nie R.G., Harris K.A., Potter R.F. Kupffer cell-initiated remote hepatic injury following bilateral hindlimb ischemia is complement dependent. Am. J. Physiol. Gastrointest. Liver Physiol. 280:2001;G279.
11. Tanaka T., Kita T., Tanaka N. The role of peptide leukotrienes in renal failure induced by a tourniquet. Forensic Sci. Int. 67:1994;89.
12. Tanaka T., Kita T., Liu R., Tanaka N. Protective effect of peptide leukotriene antagonist on renal failure induced by a tourniquet in rabbits. Forensic Sci. Int. 71:1995;57.
13. Yassin M.M., Harkin D.W., Barros D.S.A.A., Halliday M.I., Rowlands B.J. Lower limb ischemia-reperfusion injury triggers a systemic inflammatory response and multiple organ dysfunction. World J. Surg. 26:2002;115.
14. Seekamp A., Warren J.S., Remick D.G., Till G.O., Ward P.A. Requirements for tumor necrosis factor-alpha and interleukin-1 in limb ischemia/reperfusion injury and associated lung injury. Am. J. Pathol. 143:1993;453.
15. Gute D.C., Ishida T., Yarimizu K., Korthuis R.J. Inflammatory responses to ischemia and reperfusion in skeletal muscle. Mol. Cell. Biochem. 179:1998;169.
16. Welbourn R., Goldman G., O'Riordain M., Lindsay T.F., Paterson I.S., Kobzik L., Valeri C.R., Shepro D., Hechtman H.B. Role for tumor necrosis factor as mediator of lung injury following lower torso ischemia. J. Appl. Physiol. 70:1991;2645.
17. Gilmont R.R., Dardano A., Engle J.S., Adamson B.S., Welsh M.J., Li T., Remick D.G., Smith D.J. Jr, Rees R.S. TNF-alpha potentiates oxidant and reperfusion-induced endothelial cell injury. J. Surg. Res. 61:1996;175.
18. Gaines G.C., Welborn M.B. 3rd, Moldawer L.L., Huber T.S., Harward T.R., Seeger J.M. Attenuation of skeletal muscle ischemia/reperfusion injury by inhibition of tumor necrosis factor. J. Vasc. Surg. 29:1999;370.
19. Kyriakides C., Austen W.G. Jr, Wang Y., Favuzza J., Moore F.D. Jr, Hechtman H.B. Neutrophil mediated remote organ injury after lower torso ischemia and reperfusion is selectin and complement dependent. J. Trauma. 48:2000;32.
20. Harkin D.W., Barros D.S.A.A., McCallion K., Hoper M., Halliday M.I., Campbell F.C. Bactericidal/permeability-increasing protein attenuates systemic inflammation and acute lung injury in porcine lower limb ischemia-reperfusion injury. Ann. Surg. 234:2001;233.
21. Harkin D.W., Barros D.S.A.A., Yassin M.M., Hoper M., Halliday M.I., Parks T.G., Campbell F.C. Recombinant bactericidal/permeability-increasing protein attenuates the systemic inflammatory response syndrome in lower limb ischemia-reperfusion injury. J. Vasc. Surg. 33:2001;840.
22. Pemberton M., Anderson G., Vetvicka V., Justus D.E., Ross G.D. Microvascular effects of complement blockade with soluble recombinant CR1 on ischemia/reperfusion injury of skeletal muscle. J. Immunol. 150:1993;5104.
23. Bless N.M., Warner R.L., Padgaonkar V.A., Lentsch A.B., Czermak B.J., Schmal H., Friedl H.P., Ward P.A. Roles for C-X-C chemokines and C5a in lung injury after hindlimb ischemia-reperfusion. Am. J. Physiol. 276:1999;L57.
24. Kyriakides C., Austen W. Jr, Wang Y., Favuzza J., Kobzik L., Moore F.D. Jr, Hechtman H.B. Skeletal muscle reperfusion injury is mediated by neutrophils and the complement membrane attack complex. Am. J. Physiol. 277:1999;C1263.
25. Kyriakides C., Wang Y., Austen W.G. Jr, Favuzza J., Kobzik L., Moore F.D. Jr, Hechtman H.B. Moderation of skeletal muscle reperfusion injury by a sLe(x)-glycosylated complement inhibitory protein. Am. J. Physiol. Cell. Physiol. 281:2001;C224.
26. Short A., Wong A.K., Finch A.M., Haaima G., Shiels I.A., Fairlie D.P., Taylor S.M. Effects of a new C5a receptor antagonist on C5a- and endotoxin-induced neutropenia in the rat. Br. J. Pharmacol. 126:1999;551.
27. Strachan A.J., Woodruff T.M., Haaima G., Fairlie D.P., Taylor S.M. A new small molecule C5a receptor antagonist inhibits the reverse-passive Arthus reaction and endotoxic shock in rats. J. Immunol. 164:2000;6560.
28. Strachan A.J., Shiels I.A., Reid R.C., Fairlie D.P., Taylor S.M. Inhibition of immune-complex mediated dermal inflammation in rats following either oral or topical administration of a small molecule C5a receptor antagonist. Br. J. Pharmacol. 134:2001;1778.
29. Arumugam T.V., Shiels I.A., Woodruff T.M., Reid R.C., Fairlie D.P., Taylor S.M. Protective effect of a new C5a receptor antagonist against ischemia-reperfusion injury in the rat small intestine. J. Surg. Res. 103:2002;260.
30. Arumugam T.V., Shiels I.A., Strachan A.J., Abbenante G., Fairlie D.P., Taylor S.M. A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats. Kidney. Int. 63:2003;134.
31. Woodruff T.M., Strachan A.J., Dryburgh N., Shiels I.A., Reid R.C., Fairlie D.P., Taylor S.M. Anti-arthritic activity of an orally active C5a receptor antagonist against antigen-induced monoarticular arthritis in the rat. Arthritis Rhuem. 46:2002;2476.
32. Finch A.M., Wong A.K., Paczkowski N.J., Wadi S.K., Craik D.J., Fairlie D.P., Taylor S.M. Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a. J. Med. Chem. 42:1999;1965.
33. Zimmerman B.J., Granger D.N. Reperfusion injury. Surg. Clin. North. Am. 72:1992;65.
34. Homer-Vanniasinkam S., Crinnion J.N., Gough M.J. Post-ischaemic organ dysfunction A review . Eur. J. Vasc. Endovasc. Surg. 14:1997;195.
35. Collard C.D., Gelman S. Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury. Anesthesiology. 94:2001;1133.
36. Tay S.K., Ong H.T., Low P.S. Transaminitis in Duchenne's muscular dystrophy. Ann. Acad. Med. Singapore. 29:2000;719.
37. Holoman J., Glasa J., Galbavy S., Danis D., Molnarova A., Kazar J., Bednarova A., Misianik J. Serum markers of liver fibrogenesis, and liver histology findings in patients with chronic liver diseases. Bratisl. Lek. Listy. 103:2002;70.
38. Tricarico D., Capriulo R., Camerino D.C. Involvement of K(Ca(2+)) channels in the local abnormalities and hyperkalemia following the ischemia-reperfusion injury of rat skeletal muscle. Neuromuscul. Disord. 12:2002;258.
39. Walker P.M. Pathophysiology of acute arterial occlusion. Can. J. Surg. 29:1986;340.
40. Schlag M.G., Harris K.A., Potter R.F. Role of leukocyte accumulation and oxygen radicals in ischemia-reperfusion-induced injury in skeletal muscle. Am. J. Physiol. Heart Circ. Physiol. 280:2001;H1716.
41. Kajita T., Hugli T.E. C5a-induced neutrophilia. A primary humoral mechanism for recruitment of neutrophils. Am. J. Pathol. 137:1990;467.
42. Stein J.H., Osgood R.W., Barnes J.L., Reineck H.J., Pinckard R.N., McManus L.M. The role of complement in the pathogenesis of postischemic acute renal failure. Miner. Electrolyte Metab. 11:1985;256.
43. Seekamp A., Ward P.A. Ischemia-reperfusion injury. Agents Actions Suppl. 41:1993;137.
44. Dong J., Pratt J.R., Smith R.A., Dodd I., Sacks S.H. Strategies for targeting complement inhibitors in ischemia/reperfusion injury. Mol. Immunol. 36:1999;957.
45. Koller A., Kaley G. Prostaglandins mediate arteriolar dilation to increased blood flow velocity in skeletal muscle microcirculation. Circ. Res. 67:1990;529.
46. Korthuis R.J., Carden D.L., Kvietys P.R., Shepro D., Fuseler J. Phalloidin attenuates postischemic neutrophil infiltration and increased microvascular permeability. J. Appl. Physiol. 71:1991;1261.
47. Lawlor D.K., Brock R.W., Harris K.A., Potter R.F. Cytokines contribute to early hepatic parenchymal injury and microvascular dysfunction after bilateral hindlimb ischemia. J. Vasc. Surg. 30:1999;533.
48. Baumann U., Chouchakova N., Gewecke B., Kohl J., Carroll M.C., Schmidt R.E., Gessner J.E. Distinct tissue site-specific requirements of mast cells and complement components C3/C5a receptor in IgG immune complex-induced injury of skin and lung. J. Immunol. 167:2001;1022.
49. Yancey K.B. Biological properties of human C5a Selected in vitro and in vivo studies . Clin. Exp. Immunol. 71:1988;207.
50. Mollnes T.E., Brekke O.L., Fung M., Fure H., Christiansen D., Bergseth G., Videm V., Lappegard K.T., Kohl J., Lambris J.D. Essential role of the C5a receptor in E. coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood. 100:2002;1869.
51. Haynes D.R., Harkin D.G., Bignold L.P., Hutchens M.J., Taylor S.M., Fairlie D.P. Inhibition of C5a-induced neutrophil chemotaxis and macrophage cytokine production in vitro by a new C5a receptor antagonist. Biochem. Pharmacol. 60:2000;729.